论文部分内容阅读
目的:研究并分析治疗肺结核患者时使用胸腺五肽的治疗效果。方法:收集肺结核患者共92例,根据患者入院日期的单双号数分为45例对照组和47例观察组,对照组患者接受常规治疗,观察组同时使用胸腺五肽进行治疗,将两组患者不同时间的转阴率、空洞闭合情况进行观察和对比。结果:观察组患者不同时间的转阴率明显高于对照组,观察组患者的空洞闭合情况显著优于对照组(P均<0.05)。结论:在肺结核患者的治疗过程中,结合使用胸腺五肽能够有助于痰菌转阴、空洞缩小和病灶吸收,从而提高患者的生活质量,值得推广应用。
Objective: To study and analyze the therapeutic effect of thymopentin in the treatment of patients with pulmonary tuberculosis. Methods: A total of 92 patients with pulmonary tuberculosis were collected. According to the single and double numbers of admission date, the patients were divided into 45 control groups and 47 observation groups. The control group received routine treatment. The observation group was treated with thymopentin simultaneously. Patients at different times of the negative rate, empty closed for observation and comparison. Results: The rate of negative conversion in observation group was significantly higher than that in control group. The observation group was significantly better than the control group (P <0.05). Conclusion: In the treatment of patients with pulmonary tuberculosis, the combined use of thymopentin can contribute to the negative sputum bacteria, voids and lesion absorption, thereby enhancing the quality of life of patients, it is worth promoting the application.